Potencies of agonists acting at tachykinin receptors in the oestrogen-primed rat uterus: Effects of peptidase inhibitors
- 1 September 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 335 (2-3) , 221-226
- https://doi.org/10.1016/s0014-2999(97)01229-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The effects of P2 purinoceptor agonists on the isolated portal vein of the guinea pigEuropean Journal of Pharmacology, 1996
- SR 142801, The first potent non-peptide antagonist of the tachykinin NK3 receptorLife Sciences, 1994
- Differential effects of phosphoramidon and captopril on NK1 receptor-mediated plasma extravasation in the rat tracheaInflammation Research, 1994
- Tachykinin receptors in the rat isolated uterusRegulatory Peptides, 1993
- The presence of NK3 tachykinin receptors on rat uterusEuropean Journal of Pharmacology, 1991
- Selective agonists of NK-2 binding sites highly active on rat portal vein (NK-3 bioassay)Neuropeptides, 1991
- Proteolytic Inactivation of Substance P and Neurokinin A in the Longitudinal Muscle Layer of Guinea Pig Small IntestineJournal of Neurochemistry, 1986
- The hydrolysis of neurokinins A and B by cell-surface peptidasesBiochemical Society Transactions, 1986
- The metabolism of neuropeptides. Neurokinin A (substance K) is a substrate for endopeptidase-24.11 but not for peptidyl dipeptidase A (angiotensin-converting enzyme)Biochemical Journal, 1985
- Neurokinin B is hydrolysed by synaptic membranes and by endopeptidase‐24.11 (‘enkephalinase’) but not by angiotensin converting enzymeFEBS Letters, 1985